Clinical Trials in Germany — Country Dashboard | 3,920 EU Studies

Filter these 3,920 trials by condition, phase, sponsor and more.

Open in Search →

3,920 Registered trials

1,470 Recruiting

2,135 Completed trials

967 Sponsors active

2,429 Research sites

Phase III

Phase II

Phase III: 1703 Phase II/III: 163 Phase II: 1036 Phase I/II: 215 Phase III/IV: 28 Phase IV: 137 Phase I: 198 Phase I (Other): 297 Phase I (FiH): 120 Other: 22 Other: 1

Oversight events in trials active here:

118 serious breaches 845 temporary halts 65 urgent safety measures 91 unexpected events 153 corrective measures across 498 trials

View oversight register →

Top conditions

Non-small cell lung cancer 112 Systemic lupus erythematosus 38 Non-small cell lung cancer metastatic 38 Breast cancer 28 Ovarian cancer 28 Colorectal cancer 28 Rheumatoid arthritis 27 Asthma 26 Obesity 25 Crohn's disease 24 Pulmonary arterial hypertension 23 Colitis ulcerative 23

Top sponsors

Novartis Pharma AG 166 AstraZeneca AB 165 Merck Sharp & Dohme LLC 146 Boehringer Ingelheim International GmbH 127 F. Hoffmann-La Roche AG 124 Janssen - Cilag International 113 AbbVie Deutschland GmbH & Co. KG 89 Sanofi-Aventis Recherche & Developpement 80 Novo Nordisk A/S 67 Pfizer Inc. 67 Eli Lilly & Co. 59 Amgen Inc. 58

Cities with most trials

All 569 cities →

All trials — page 49

3,920 total

A Study to Compare the Efficacy and Safety of Vedolizumab With and Without Upadacitinib in Adults With Moderately to Severely Active Crohn's… Recruiting

2023-509391-42-00 Phase III/IV Chron's Disease Takeda Development Center Americas Inc.
An Open-label, Global, Multi-Arm Study to Evaluate the Efficacy and Safety of Relacorilant in Combination with Different Treatment Regimens … Recruiting

2024-517432-21-00 Phase II Gynecological Cancers Corcept Therapeutics Inc.
A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellit… Recruiting

2024-518470-13-00 Phase I (Other) Diabetes Mellitus Eli Lilly & Co.
Assessment of the safety and efficacy of a hepatitis B vaccine in adult patients with hepatitis B Recruiting

2023-507623-36-00 Phase I/II Chronic hepatitis B Klinikum der Universitaet Muenchen AöR
A Phase I/II study of GSK5733584 in combination with anti-cancer therapies for advanced solid tumors Recruiting

2024-517147-31-00 Phase I/II Tumours, Gynecological Glaxosmithkline Research & Development Limited
A study Investigating Subcutaneously Administered Pozelimab in Combination with Cemdisiran or Cemdisiran Alone in Adult Participants with Ge… Recruiting

2023-509547-27-00 Phase III Geographic Atrophy Secondary to Age-Related Macular Degenera… Regeneron Pharmaceuticals Inc.
Randomized, placebo-controlled clinical trial to investigate the safety and efficacy of two dexamfetamine sulfate formulations in adults wit… Recruiting

2024-515395-12-00 Phase II Adults with ADHD and moderate to severe depression Fraunhofer Institute For Translational Medicine And Pharmacology ITMP
Differences in absorption via oral route and via oral mucosa of hydrocortisone from 2-dimensionally printed dissolvable films in healthy vol… Recruiting

2024-517298-26-00 adrenal insufficiency Universitaetsklinikum Heidelberg AöR
Long-term study evaluating joint health in people with haemophilia A receiving real-world prophylactic treatment with efanesoctocog alfa Recruiting

2024-517812-31-00 Phase IV Haemophilia A Swedish Orphan Biovitrum AB (publ)
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) Recruiting

2024-514937-39-00 Phase III Dravet Syndrome Longboard Pharmaceuticals Inc.
A clinical study of zilovertamab vedotin with R-CHP treatment in people with diffuse large B-cell lymphoma (MK-2140-011) Recruiting

2024-515526-89-00 Phase II Diffuse Large B-Cell Lymphoma (DLBCL) Merck Sharp & Dohme LLC
A study to find how well Dazodalibep works and how safe it is in participants with Sjôgren`s Syndrome Recruiting

2024-517513-32-00 Phase III Sjögren’s Syndrome Amgen Inc.
A clinical study of V940 and pembrolizumab to treat lung cancer (V940-009) Recruiting

2023-506327-29-00 Phase III Non-Small Cell Lung Cancer Merck Sharp & Dohme LLC
A Study of LY4057996 in Healthy Participants and Participants with Type 1 and Type 2 Diabetes (YKAA) Recruiting

2024-519151-28-00 Phase I Healthy, Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Eli Lilly & Co.
A study with three treatments for higher-risk chronic myelomonocytic leukaemia. Recruiting

2024-511102-22-00 Phase II chronic myelomonocytic Leukemia GCP-Service International West GmbH
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia Trial Recruiting

2024-511828-14-00 Phase II Type II diabetes melittus (10067585) Kantonsspital Baden AG
A study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia Recruiting

2024-517706-29-00 Phase III Ataxia Telangiectasia Intrabio Limited
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy Recruiting

2024-514689-38-01 Phase II Pain Associated With Diabetic Peripheral Neuropathy Vertex Pharmaceuticals Inc.
A Study of Duvelisib Versus the Anti-cancer Drugs Gemcitabine or Bendamustine in Patients With T Cell lymphoma (a type of blood cancer), whi… Recruiting

2024-516605-23-00 Phase III relapsed/refractory nodal T cell lymphoma with T follicular … Secura Bio Limited
A Phase 3, multicenter, open label, randomized, non-comparative two-arm study of ivosidenib monotherapy (IVO) and azacitidine monotherapy (A… Recruiting

2023-510155-37-00 Phase III Hypomethylating agent (HMA) naive myelodysplastic syndromes … Institut De Recherches Internationales Servier IRIS
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adult Patients Wi… Recruiting

2024-515593-27-00 Phase III relapsed or refractory mantle cell lymphoma (R/R MCL) BeOne Medicines AG
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin on clinical outcomes alone and how safe it is in adu… Recruiting

2023-506460-14-00 Phase III Chronic kidney disease (CKD) and hypertension. Astrazeneca AB
FusionVAC22_02: DNAJB1-PRKACA fusion transcript-based peptide vaccine for fibrolamellar hepatocellular carcinoma patients and other tumor en… Recruiting

2024-519387-41-00 Phase I tumor entities carrying the oncogenic driver fusion Universitaetsklinikum Tuebingen AöR
A clinical trial to evaluate the safety and the efficacy of NEXAGON ® (Lufepirsen Ophthalmic Gel) in subjects with Persistent Corneal Epithe… Recruiting

2023-507030-24-00 Phase II Persistent Corneal Epithelial Defects Glaukos Corp.

Showing 1,153–1,176 of 3,920 trials

← All countries